 |
Amplia Therapeutics
Last updated: January 26, 2024
Christopher Burns, CEO
Country: Australia | Add Funding
Website: https://www.ampliatx.com/site/content/
Amplia Therapeutics develops focal adhesion kinase (FAK) inhibitors as solutions for treating pancreatic and ovarian cancer.
Website: https://www.ampliatx.com/site/content/
Amplia Therapeutics develops focal adhesion kinase (FAK) inhibitors as solutions for treating pancreatic and ovarian cancer.
